In Veritas Medical Diagnostics, Inc. (IVME)

IVME Income Statement

Financials in millions USD. Fiscal year is August - July.

Fiscal Year	TTM	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003
Period Ending	Jan 31, 2008	Jul 31, 2007	Jul 31, 2006	Jul 31, 2005	Jul 31, 2004	Sep 30, 2003
Revenue	-	-	1.27	0.88	0.76	0.29
Revenue Growth (YoY)	-	-	44.47%	15.69%	165.45%	-
Cost of Revenue	-	-	-	0	0	0.01
Gross Profit	-	-	1.27	0.88	0.76	0.28
Selling, General & Admin	1.33	2.01	0.92	1.15	0.89	0.76
Research & Development	0.74	0.71	1.21	1.34	0.87	0.19
Operating Expenses	2.07	2.72	2.13	2.55	1.78	0.96
Operating Income	-2.07	-2.72	-0.86	-1.67	-1.02	-0.68
Interest Expense	-1.06	-0.95	-0.74	-0.63	-	-
Currency Exchange Gain (Loss)	-	-	-0	-0.13	-	-
EBT Excluding Unusual Items	-3.13	-3.67	-1.6	-2.43	-1.02	-0.68
Other Unusual Items	-	-	-0.25	-0.02	-	-
Pretax Income	-3.13	-3.67	-1.85	-2.45	-1.02	-0.68
Net Income	-3.13	-3.67	-1.85	-2.45	-1.02	-0.68
Net Income to Common	-3.13	-3.67	-1.85	-2.45	-1.02	-0.68
Shares Outstanding (Basic)	61	59	55	53	12	0
Shares Outstanding (Diluted)	61	59	55	53	12	0
Shares Change (YoY)	7.23%	7.35%	4.86%	342.87%	60403.13%	-99.82%
EPS (Basic)	-0.05	-0.06	-0.03	-0.05	-0.09	-34.93
EPS (Diluted)	-0.05	-0.06	-0.03	-0.05	-0.09	-34.93
Free Cash Flow	-0.36	-0.73	-0.64	-0.76	-0.81	-0.89
Free Cash Flow Per Share	-0.01	-0.01	-0.01	-0.01	-0.07	-45.51
Gross Margin	-	-	100.00%	99.48%	99.89%	97.24%
Operating Margin	-	-	-67.86%	-189.81%	-133.72%	-239.08%
Profit Margin	-	-	-145.44%	-278.55%	-133.72%	-239.08%
Free Cash Flow Margin	-	-	-50.55%	-86.16%	-106.78%	-311.50%
EBITDA	-2.07	-2.71	-0.85	-1.64	-1	-0.67
EBITDA Margin	-	-	-66.56%	-186.63%	-130.84%	-234.30%
D&A For EBITDA	0	0.01	0.02	0.03	0.02	0.01
EBIT	-2.07	-2.72	-0.86	-1.67	-1.02	-0.68
EBIT Margin	-	-	-67.86%	-189.81%	-133.72%	-239.08%

Updated Mar 14, 2008. Source: S&P Global Market Intelligence. Standard template. Financial Sources.